Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.

Mnika K, Pule GD, Dandara C, Wonkam A.

OMICS. 2016 Oct;20(10):565-574. Epub 2016 Sep 16.

PMID:
27636225
2.

Community Health Workers as Support for Sickle Cell Care.

Hsu LL, Green NS, Donnell Ivy E, Neunert CE, Smaldone A, Johnson S, Castillo S, Castillo A, Thompson T, Hampton K, Strouse JJ, Stewart R, Hughes T, Banks S, Smith-Whitley K, King A, Brown M, Ohene-Frempong K, Smith WR, Martin M.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S87-98. doi: 10.1016/j.amepre.2016.01.016.

3.

Nurses' attitudes toward patients with sickle cell disease: a worksite comparison.

Jenerette CM, Pierre-Louis BJ, Matthie N, Girardeau Y.

Pain Manag Nurs. 2015 Jun;16(3):173-81. doi: 10.1016/j.pmn.2014.06.007.

4.

A Survey of the Pain Management of Acute Painful Crisis among Patients with Sickle Cell Disease at Two Centres in Jamaica.

Augier R, Jenkins S, Bortolusso Ali S, Tennant I, Williams-Johnson J, Reid M.

West Indian Med J. 2014 Jun;63(3):252-7. doi: 10.7727/wimj.2013.333. Epub 2014 Jun 12.

5.

Voices of Adults Living with Sickle Cell Disease Pain.

Adegbola MA, Barnes DM, Opollo JG, Herr K, Gray J, McCarthy AM.

J Natl Black Nurses Assoc. 2012 Dec;23(2):16-23.

6.

Ethnicity interacts with the OPRM1 gene in experimental pain sensitivity.

Hastie BA, Riley JL 3rd, Kaplan L, Herrera DG, Campbell CM, Virtusio K, Mogil JS, Wallace MR, Fillingim RB.

Pain. 2012 Aug;153(8):1610-9. doi: 10.1016/j.pain.2012.03.022. Epub 2012 Jun 18.

7.

Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.

Barrett MJ, Cronin J, Murphy A, McCoy S, Hayden J, an FhailĂ­ S, Grant T, Wakai A, McMahon C, Walsh S, O'Sullivan R.

Trials. 2012 May 30;13:74. doi: 10.1186/1745-6215-13-74.

8.

Genomics and pain research in sickle cell disease: an explanation of heterogeneity?

Adegbola M.

ISRN Nurs. 2011;2011:672579. doi: 10.5402/2011/672579. Epub 2011 Apr 20.

9.
10.

The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan.

Perampaladas K, Masum H, Kapoor A, Shah R, Daar AS, Singer PA.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S11. doi: 10.1186/1472-698X-10-S1-S11.

11.

Health-related stigma in young adults with sickle cell disease.

Jenerette CM, Brewer C.

J Natl Med Assoc. 2010 Nov;102(11):1050-5.

12.

A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic.

Lazio MP, Costello HH, Courtney DM, Martinovich Z, Myers R, Zosel A, Tanabe P.

Clin J Pain. 2010 Mar-Apr;26(3):199-205. doi: 10.1097/AJP.0b013e3181bed10c.

13.

Successful Aging with Sickle Cell Disease: Using Qualitative Methods to Inform Theory.

Jenerette CM, Lauderdale G.

J Theory Constr Test. 2008 Apr 1;12(1):16-24.

Supplemental Content

Support Center